SI21403A - Farmacevtska oblika z alendronsko kislino, njenimi solmi ali estri ter postopek za njeno pripravo - Google Patents

Farmacevtska oblika z alendronsko kislino, njenimi solmi ali estri ter postopek za njeno pripravo Download PDF

Info

Publication number
SI21403A
SI21403A SI200300052A SI200300052A SI21403A SI 21403 A SI21403 A SI 21403A SI 200300052 A SI200300052 A SI 200300052A SI 200300052 A SI200300052 A SI 200300052A SI 21403 A SI21403 A SI 21403A
Authority
SI
Slovenia
Prior art keywords
pharmaceutically acceptable
pharmaceutical
form according
pharmaceutical form
group
Prior art date
Application number
SI200300052A
Other languages
English (en)
Slovenian (sl)
Inventor
Miha Toma� Jakli�
Vlasta Humar
Debeljak Helena �uklje
Judita �irca
Milojka Mohar
Original Assignee
LEK farmacevtska dru�ba d.d.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LEK farmacevtska dru�ba d.d. filed Critical LEK farmacevtska dru�ba d.d.
Priority to SI200300052A priority Critical patent/SI21403A/sl
Priority to PL377706A priority patent/PL377706A1/pl
Priority to EP04714997A priority patent/EP1599191B1/fr
Priority to DE602004026689T priority patent/DE602004026689D1/de
Priority to EA200501221A priority patent/EA009333B1/ru
Priority to PCT/SI2004/000011 priority patent/WO2004075828A2/fr
Priority to CA2517372A priority patent/CA2517372C/fr
Priority to AT04714997T priority patent/ATE464884T1/de
Publication of SI21403A publication Critical patent/SI21403A/sl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
    • A61K31/663—Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SI200300052A 2003-02-27 2003-02-27 Farmacevtska oblika z alendronsko kislino, njenimi solmi ali estri ter postopek za njeno pripravo SI21403A (sl)

Priority Applications (8)

Application Number Priority Date Filing Date Title
SI200300052A SI21403A (sl) 2003-02-27 2003-02-27 Farmacevtska oblika z alendronsko kislino, njenimi solmi ali estri ter postopek za njeno pripravo
PL377706A PL377706A1 (pl) 2003-02-27 2004-02-26 Kompozycja farmaceutyczna zawierająca kwas alendronowy, jego sole lub estry oraz sposób jej otrzymywania
EP04714997A EP1599191B1 (fr) 2003-02-27 2004-02-26 Composition pharmaceutique a base d'acide alendronique, de sels ou d'esters de celui-ci et procede de preparation de cette composition
DE602004026689T DE602004026689D1 (de) 2003-02-27 2004-02-26 Pharmazeutische zusammensetzung von alendronsäure, salze und ester davon, und ein verfahren zu deren herstellung
EA200501221A EA009333B1 (ru) 2003-02-27 2004-02-26 Фармацевтическая композиция алендроновой кислоты, ее солей или сложных эфиров и способ ее получения
PCT/SI2004/000011 WO2004075828A2 (fr) 2003-02-27 2004-02-26 Composition pharmaceutique a base d'acide alendronique, de sels ou d'esters de celui-ci et procede de preparation de cette composition
CA2517372A CA2517372C (fr) 2003-02-27 2004-02-26 Composition pharmaceutique a base d'acide alendronique, de sels ou d'esters de celui-ci et procede de preparation de cette composition
AT04714997T ATE464884T1 (de) 2003-02-27 2004-02-26 Pharmazeutische zusammensetzung von alendronsäure,salze und ester davon, und ein verfahren zu deren herstellung

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SI200300052A SI21403A (sl) 2003-02-27 2003-02-27 Farmacevtska oblika z alendronsko kislino, njenimi solmi ali estri ter postopek za njeno pripravo

Publications (1)

Publication Number Publication Date
SI21403A true SI21403A (sl) 2004-08-31

Family

ID=32906916

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200300052A SI21403A (sl) 2003-02-27 2003-02-27 Farmacevtska oblika z alendronsko kislino, njenimi solmi ali estri ter postopek za njeno pripravo

Country Status (8)

Country Link
EP (1) EP1599191B1 (fr)
AT (1) ATE464884T1 (fr)
CA (1) CA2517372C (fr)
DE (1) DE602004026689D1 (fr)
EA (1) EA009333B1 (fr)
PL (1) PL377706A1 (fr)
SI (1) SI21403A (fr)
WO (1) WO2004075828A2 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1781258A1 (fr) * 2004-08-20 2007-05-09 Mepha AG Formulations de bisphosphonates
WO2006054165A1 (fr) * 2004-11-19 2006-05-26 Ranbaxy Laboratories Limited Compositions pharmaceutiques de l'acide alendronique et leur procede de preparation
PE20070698A1 (es) * 2005-11-14 2007-08-17 Teijin Pharma Ltd Comprimido de disgregacion rapida intraoral que contiene hidrocloruro de ambroxol
US20080131467A1 (en) * 2006-11-30 2008-06-05 Dennis Nelson Film-coated solid dosage form
WO2009018834A1 (fr) * 2007-08-06 2009-02-12 Pharmathen S.A. Composition pharmaceutique contenant du biphosphonate et son procédé de préparation
WO2012085043A2 (fr) * 2010-12-22 2012-06-28 Basf Se Forme pharmaceutique solide enrobée à désagrégation rapide
US8715729B2 (en) 2010-12-22 2014-05-06 Basf Se Rapidly disintegrating, solid coated dosage form
CN116211818B (zh) * 2023-03-10 2024-04-09 菲洋生物科技(吉林)有限公司 一种含有阿仑膦酸钠的片剂及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL121623A (en) * 1997-08-26 2000-06-29 Unipharm Ltd Process for the preparation of solid oral dosage forms comprising alendronic acid
US6432448B1 (en) * 1999-02-08 2002-08-13 Fmc Corporation Edible coating composition
WO2001026633A1 (fr) * 1999-10-11 2001-04-19 Monsanto Company Comprimes enrobes de gomme de caroube, de gomme de guar ou de gomme de mousse d'irlande
US6476006B2 (en) * 2000-06-23 2002-11-05 Teva Pharmaceutical Industries, Ltd. Composition and dosage form for delayed gastric release of alendronate and/or other bis-phosphonates

Also Published As

Publication number Publication date
EP1599191A2 (fr) 2005-11-30
WO2004075828A3 (fr) 2004-10-28
WO2004075828A2 (fr) 2004-09-10
CA2517372A1 (fr) 2004-09-10
CA2517372C (fr) 2012-07-17
EA200501221A1 (ru) 2006-04-28
ATE464884T1 (de) 2010-05-15
PL377706A1 (pl) 2006-02-06
EP1599191B1 (fr) 2010-04-21
DE602004026689D1 (de) 2010-06-02
EA009333B1 (ru) 2007-12-28

Similar Documents

Publication Publication Date Title
ES2921141T3 (es) Forma farmacéutica oral sólida entérica de un bisfosfonato que contiene un agente quelante
RU2381791C2 (ru) Лекарственные формы ризедроната
JP5037746B2 (ja) イバンドロネートを含む経口薬理製剤
US20070104786A1 (en) Dosage forms for immediate gastric release of a calcium transport stimulator coupled with delayed gastric release of a bis-phosphonate
US20050026871A1 (en) Method of increasing bioavailability of alendronate or other bis-phosphonate by predose administration of vitamin D derivative
JP2004501186A (ja) アレンドロン酸塩及び／又はその他のビスホスホン酸塩の遅延型胃内放出のための組成物及び製剤
US10420725B2 (en) Solid dosage form of coated bisphosphonate particles
SI21403A (sl) Farmacevtska oblika z alendronsko kislino, njenimi solmi ali estri ter postopek za njeno pripravo
CN113490491A (zh) 固体微粉化褪黑激素组合物
EP1617826B1 (fr) Formulation dispersible de microparticules d'alendronate

Legal Events

Date Code Title Description
IF Valid on the event date
KO00 Lapse of patent

Effective date: 20130307